Company intelligence / Profile preview

I&V-BIO

Ownership: Private
Employees: ~35
Development stage: Other

Overview

I&V-BIO provides daily deliveries of live and enriched Artemia nauplii to shrimp and fish hatcheries worldwide using patented separation and hatching protocols. The company has established itself as a leader in consistent quality supply of specialty feeds in the global aquaculture market.

Industry: Agriculture & AgTech

Partnerships

Skretting (strategic partnership to revolutionize artemia enrichment using ORI-N3)

Beyond the preview

Go deeper on I&V-BIO.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on I&V-BIO.

Explore the full profile